Indiana SB 514: Chimeric antigen receptor T-cell therapy.

Status: First reading: referred to Committee on Health and Provider Services (as of 2025-01-16)

State: Indiana · Session: 2025 · Bill: SB 514

Subjects: AGENCIES; Department of Health (IDOH), AGENCIES; Family and Social Services Administration (FSSA), HEALTH CARE FACILITIES; Generally, INSURANCE; Health Insurance, INSURANCE; Health Maintenance Organizations (HMOs), INSURANCE; Motor Vehicles

Sponsors: Jean Leising

View Indiana SB 514 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.